1. Home
  2. CCG vs BYSI Comparison

CCG vs BYSI Comparison

Compare CCG & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$17.11

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.72

Market Cap

35.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCG
BYSI
Founded
2014
2010
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
35.8M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
CCG
BYSI
Price
$17.11
$0.72
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$350.00
N/A
AVG Volume (30 Days)
19.7K
1.9M
Earning Date
05-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$567.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.67
52 Week High
$17.99
$2.44

Technical Indicators

Market Signals
Indicator
CCG
BYSI
Relative Strength Index (RSI) 67.30 33.47
Support Level $0.65 N/A
Resistance Level N/A $1.30
Average True Range (ATR) 1.86 0.12
MACD -0.27 0.00
Stochastic Oscillator 70.38 11.04

Price Performance

Historical Comparison
CCG
BYSI

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: